MTOR and hepatocellular carcinoma: Similarly, Ji et al. (21) showed that LINC00152 could activate the mammalian target of rapamycin (mTOR) signaling pathway through a combination of EpCAM promoters in a cis-regulated manner, which promotes HCC cell proliferation in vitro and tumor growth in vivo (21).